Restatement
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Exchange
- Nasdaq
- State of incorporation
- DE
- Form
- 8-K
- Filed
- June 17, 2022
Filings & documents
Every entry traces to SEC EDGAR. The Information Statement is the primary source; the links below open the full filing and each company's complete filing history.
Source filing ↗8-K · the filing we parseAll documents in this filing ↗accession 0001140361-22-023519Ernexa Therapeutics Inc. — all SEC filings ↗EDGAR company page
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.